SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-003973
Filing Date
2018-03-01
Accepted
2018-03-01 08:40:55
Documents
3
Period of Report
2018-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20180227.htm 8-K 37287
2 EX-10.1 insy-ex101_7.htm EX-10.1 292559
3 EX-10.2 insy-ex102_6.htm EX-10.2 304497
  Complete submission text file 0001564590-18-003973.txt   635477
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 18654804
SIC: 2834 Pharmaceutical Preparations